BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27811125)

  • 1. Human Biodistribution and Radiation Dosimetry of
    Barrio MJ; Spick C; Radu CG; Lassmann M; Eberlein U; Allen-Auerbach M; Schiepers C; Slavik R; Czernin J; Herrmann K
    J Nucl Med; 2017 Mar; 58(3):374-378. PubMed ID: 27811125
    [No Abstract]   [Full Text] [Related]  

  • 2. Human biodistribution and radiation dosimetry of novel PET probes targeting the deoxyribonucleoside salvage pathway.
    Schwarzenberg J; Radu CG; Benz M; Fueger B; Tran AQ; Phelps ME; Witte ON; Satyamurthy N; Czernin J; Schiepers C
    Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):711-21. PubMed ID: 21127859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stratification of nucleoside analog chemotherapy using 1-(2'-deoxy-2'-18F-fluoro-β-D-arabinofuranosyl)cytosine and 1-(2'-deoxy-2'-18F-fluoro-β-L-arabinofuranosyl)-5-methylcytosine PET.
    Lee JT; Campbell DO; Satyamurthy N; Czernin J; Radu CG
    J Nucl Med; 2012 Feb; 53(2):275-80. PubMed ID: 22302964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel PET probes specific for deoxycytidine kinase.
    Shu CJ; Campbell DO; Lee JT; Tran AQ; Wengrod JC; Witte ON; Phelps ME; Satyamurthy N; Czernin J; Radu CG
    J Nucl Med; 2010 Jul; 51(7):1092-8. PubMed ID: 20554721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity.
    Kim W; Le TM; Wei L; Poddar S; Bazzy J; Wang X; Uong NT; Abt ER; Capri JR; Austin WR; Van Valkenburgh JS; Steele D; Gipson RM; Slavik R; Cabebe AE; Taechariyakul T; Yaghoubi SS; Lee JT; Sadeghi S; Lavie A; Faull KF; Witte ON; Donahue TR; Phelps ME; Herschman HR; Herrmann K; Czernin J; Radu CG
    Proc Natl Acad Sci U S A; 2016 Apr; 113(15):4027-32. PubMed ID: 27035974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution and radiation dosimetry of (68)Ga-PSMA HBED CC-a PSMA specific probe for PET imaging of prostate cancer.
    Pfob CH; Ziegler S; Graner FP; Köhner M; Schachoff S; Blechert B; Wester HJ; Scheidhauer K; Schwaiger M; Maurer T; Eiber M
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1962-70. PubMed ID: 27207281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human Study.
    Bretin F; Bahri MA; Bernard C; Warnock G; Aerts J; Mestdagh N; Buchanan T; Otoul C; Koestler F; Mievis F; Giacomelli F; Degueldre C; Hustinx R; Luxen A; Seret A; Plenevaux A; Salmon E
    Mol Imaging Biol; 2015 Aug; 17(4):557-64. PubMed ID: 25595813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodistribution and radiation dosimetry of deuterium-substituted 18F-fluoromethyl-[1, 2-2H4]choline in healthy volunteers.
    Challapalli A; Sharma R; Hallett WA; Kozlowski K; Carroll L; Brickute D; Twyman F; Al-Nahhas A; Aboagye EO
    J Nucl Med; 2014 Feb; 55(2):256-63. PubMed ID: 24492392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-ICMT-11, a caspase-3-specific PET tracer for apoptosis: biodistribution and radiation dosimetry.
    Challapalli A; Kenny LM; Hallett WA; Kozlowski K; Tomasi G; Gudi M; Al-Nahhas A; Coombes RC; Aboagye EO
    J Nucl Med; 2013 Sep; 54(9):1551-6. PubMed ID: 23949910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodistribution and Radiation Dosimetry of
    Garg PK; Lokitz SJ; Nazih R; Garg S
    J Nucl Med; 2017 Mar; 58(3):473-478. PubMed ID: 27660145
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Nishii R; Higashi T; Kagawa S; Okuyama C; Kishibe Y; Takahashi M; Okina T; Suzuki N; Hasegawa H; Nagahama Y; Ishizu K; Oishi N; Kimura H; Watanabe H; Ono M; Saji H; Yamauchi H
    Ann Nucl Med; 2018 May; 32(4):256-263. PubMed ID: 29453681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation dosimetry of [
    Lee N; Oh I; Chae SY; Jin S; Oh SJ; Lee SJ; Koglin N; Berndt M; Stephens AW; Oh JS; Moon DH
    Nucl Med Biol; 2019; 72-73():45-48. PubMed ID: 31330411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of [18F]Mefway biodistribution and dosimetry based on whole-body PET imaging of mice.
    Constantinescu CC; Sevrioukov E; Garcia A; Pan ML; Mukherjee J
    Mol Imaging Biol; 2013 Apr; 15(2):222-9. PubMed ID: 22833323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First Evaluation of PET-Based Human Biodistribution and Dosimetry of
    Savi A; Incerti E; Fallanca F; Bettinardi V; Rossetti F; Monterisi C; Compierchio A; Negri G; Zannini P; Gianolli L; Picchio M
    J Nucl Med; 2017 Aug; 58(8):1224-1229. PubMed ID: 28209906
    [No Abstract]   [Full Text] [Related]  

  • 15. Pilot pharmacokinetic and dosimetric studies of (18)F-FPPRGD2: a PET radiopharmaceutical agent for imaging α(v)β(3) integrin levels.
    Mittra ES; Goris ML; Iagaru AH; Kardan A; Burton L; Berganos R; Chang E; Liu S; Shen B; Chin FT; Chen X; Gambhir SS
    Radiology; 2011 Jul; 260(1):182-91. PubMed ID: 21502381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PET.
    Krebs S; Veach DR; Carter LM; Grkovski M; Fornier M; Mauro MJ; Voss MH; Danila DC; Burnazi E; Null M; Staton K; Pressl C; Beattie BJ; Zanzonico P; Weber WA; Lyashchenko SK; Lewis JS; Larson SM; Dunphy MPS
    J Nucl Med; 2020 Nov; 61(11):1580-1587. PubMed ID: 32169913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution and radiation dosimetry of D-isomer of 4-borono-2-[
    Yang Q; Zhu W; Ren C; Ji H; Wang D; Liu Y; Li F; Du Y; Liu Y; Huo L
    Nucl Med Biol; 2021; 94-95():32-37. PubMed ID: 33486437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteers.
    Doss M; Kolb HC; Walsh JC; Mocharla V; Fan H; Chaudhary A; Zhu Z; Alpaugh RK; Lango MN; Yu JQ
    J Nucl Med; 2013 Dec; 54(12):2087-92. PubMed ID: 24136934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [(68)Ga]NODAGA-RGD - Metabolic stability, biodistribution, and dosimetry data from patients with hepatocellular carcinoma and liver cirrhosis.
    Haubner R; Finkenstedt A; Stegmayr A; Rangger C; Decristoforo C; Zoller H; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2005-13. PubMed ID: 27164900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodistribution and radiation dosimetry of the integrin marker 18F-RGD-K5 determined from whole-body PET/CT in monkeys and humans.
    Doss M; Kolb HC; Zhang JJ; Bélanger MJ; Stubbs JB; Stabin MG; Hostetler ED; Alpaugh RK; von Mehren M; Walsh JC; Haka M; Mocharla VP; Yu JQ
    J Nucl Med; 2012 May; 53(5):787-95. PubMed ID: 22499613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.